Sometimes it takes a major shift is the world to see things differently. As editor of DAIC, I often wonder if the ...
May 27, 2021 — Philips Healthcare released a workhorse computed tomography (CT) system, the Spectral CT 7500, which has ...
Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated ...
May 25, 2021 — Acutus Medical Inc. announced European CE mark approval for a broad suite of electrophysiology (EP) ...
May 25, 2021 — iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...
May 19, 2021 — Among patients with both heart failure and atrial fibrillation (AFib), treatment strategies focused on ...
May 19, 2021 — A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The ability of a cardiologist to work remotely can save lives. By leveraging the advantages of a cloud-based ...
May 18, 2021 — Artificial intelligence (AI) derived heart measurements were able to predict COVID-19 (SARS-CoV-2) ...
May 18, 2021 — The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...
May 18, 2021 — Dapagliflozin (Farxiga), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, did not significantly ...
Ehtisham Mahmud, M.D., division chief of cardiovascular medicine, director of interventional cardiology and the cardiac ...